2025-12-21 - Analysis Report
Okay, here's a comprehensive analysis of Procter & Gamble (PG) based on the data you provided.

**0) Report Structure**

The report will first present the data in a simple, numerical format, and then follow with an analysis of each section.  Finally, a comprehensive summary will integrate all the information.

**1) Return Rate Comparison**

*   **Ticker:** PG
*   **Company Name:** Procter & Gamble Co
*   **Overview:** Procter & Gamble is a multinational consumer goods corporation that manufactures and markets a wide range of branded products.
*   **PG Cumulative Return:** 26.13%
*   **S&P 500 (VOO) Cumulative Return:** 100.88%
*   **Divergence:** -73.0 (Relative Divergence: 7.0)

**Analysis:**

PG has significantly underperformed the S&P 500 over the period covered by the cumulative return data.  The divergence of -73.0 indicates a substantial gap in performance. The relative divergence of 7.0 suggests that the current underperformance is near the low end of its historical range relative to the S&P 500. This *could* imply that PG might be undervalued compared to its past performance relative to the market, *or* it could suggest a fundamental shift in its relative attractiveness.

**Alpha, Beta Analysis Table**

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
|------------|--------|-------|--------|------|--------|
| 2015-2017  | 21.0%  | 7.9%  | -8.0%  | 0.0  | 215.0  |
| 2016-2018  | 9.0%   | 67.3% | -6.0%  | 0.1  | 215.1  |
| 2017-2019  | 24.0%  | 70.4% | 2.0%   | 0.3  | 292.3  |
| 2018-2020  | 27.0%  | 78.8% | 4.0%   | 0.4  | 325.7  |
| 2019-2021  | 41.0%  | 78.8% | -5.0%  | 0.5  | 382.9  |
| 2020-2022  | 13.0%  | 79.4% | 13.0%  | 0.6  | 354.7  |
| 2021-2023  | 26.0%  | 79.4% | 24.0%  | 0.4  | 343.0  |
| 2022-2024  | 9.0%   | 79.4% | -12.0% | 0.4  | 392.4  |
| 2023-2025  | -18.0% | 80.1% | -83.0% | 0.1  | 338.1  |

**Analysis:**

*   **CAGR:**  The Compound Annual Growth Rate shows inconsistent performance, with a recent significant drop. The most recent 2023-2025 period shows a negative return.
*   **MDD:** The Maximum Drawdown has been high over the last few periods, indicating significant price volatility and potential for loss.
*   **Alpha:**  Alpha, which represents the excess return compared to the market, has been highly variable. Notably, the most recent period shows a very negative Alpha, implying significant underperformance relative to its benchmark.
*   **Beta:**  Beta, a measure of volatility relative to the market, is relatively low, indicating that PG is generally less volatile than the overall market.
*   **Cap(B):**  Market capitalization has fluctuated.

**2) Recent Stock Price Fluctuations**

*   **Close:** 144.46
*   **Last-market:** {'price': 144.46, 'previousClose': 145.52, 'change': -0.73}
*   **5-day SMA:** 145.63
*   **20-day SMA:** 144.91
*   **60-day SMA:** 148.06

**Analysis:**

The current closing price (144.46) is below the 5-day, 20-day, and 60-day Simple Moving Averages. This *could* suggest a short-term downward trend.  The price decrease (-0.73 from the previous close) reinforces this idea. The 5-day SMA is below the 20-day SMA, which is further below the 60-day SMA, confirming the downward trend.

**3) RSI, PPO, and Divergence Analysis**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 47.18
*   **PPO:** 0.33
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 5.8 (+) (단기상승 - Short-term increase)
*   **Expected Return (%):** 2.2

**Analysis:**

*   **MRI:** The MRI of 0.7 suggests a "Medium Investment" recommendation, reflecting moderate risk.
*   **RSI:** An RSI of 47.18 is neutral, indicating neither overbought nor oversold conditions.
*   **PPO:** The Positive value implies an upward movement for the stock but it is small and not very meaningul
*   **Hybrid Signal:** The "Buy" signal is a positive sign, driven by an MRI of 0.90.  The recommendation to invest 100% of cash *and* invest a fixed amount monthly implies a belief in the stock's long-term potential.
*   **Recent Divergence Change:** The positive change in relative divergence over the last 20 days suggests a recent improvement in PG's performance relative to the S&P 500.
*   **Expected Return:** A 2.2% expected return is relatively modest, implying that analysts don't foresee significant near-term gains.

**4) Recent News & Significant Events**

*   **[2025-12-06] How Good Has PG Stock Actually Been? - The Motley Fool / Yahoo Finance:** This article suggests an analysis of PG's historical performance, likely questioning whether past success is indicative of future returns, especially in light of its recent underperformance.
*   **[2025-12-16] Jim Cramer identifies his favorite portfolio stock — and it’s not a big tech name - CNBC:**  While PG is not mentioned directly, the article suggests a move away from high-growth tech stocks, which *could* indirectly benefit stable, dividend-paying stocks like PG if investors seek safer havens.
*   **[2025-12-19] Procter & Gamble (PG) Stock News Today: December 19, 2025 Updates, Analyst Forecasts, Price Targets, and What to Watch Next - ts2.tech:**  This signals ongoing analyst activity and potential catalysts to watch for.
*   **[2025-12-17] Buy PG Stock Over Colgate-Palmolive? - Forbes:** This suggests a comparative analysis, potentially highlighting the relative attractiveness of PG within its industry.
*   **[2025-12-20] Procter & Gamble (PG): Reassessing Valuation After Jefferies’ Upgrade and AI-Driven Efficiency Push - simplywall.st:** This is very positive. It suggests that Jefferies upgraded PG and that PG is looking to improve efficiency. This may address any fundamental issues.

**Analysis:**

The news headlines present a mixed picture.  The articles discussing PG's historical performance suggest caution.  The article about Jefferies upgrading PG and AI-Driven Efficiency Push is positive. The comparisons to Colgate-Palmolive are neutral without reading the article. All in all, there's nothing immediately detrimental, and some potentially positive catalysts on the horizon.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (~Buy)
*   **Opinions:** 22
*   **Target Price (avg/high/low):** 168.95 / 186.00 / 148.00
*   **Recent Rating Changes:** Not provided with information

**Analysis:**

The analyst consensus is "Buy," suggesting that analysts generally believe the stock is undervalued.  The average target price of 168.95 indicates a potential upside from the current price of 144.46. However, the "Buy" rating may not be as strong since it is nearer the middle range of the 1-5 rating scale. Without information on recent rating changes, it's difficult to assess the trend in analyst sentiment.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-10-24 | 2.00 | 22.39 B$    |
| 2025-04-24 | 1.58 | 19.78 B$    |
| 2025-01-22 | 1.94 | 21.88 B$    |
| 2024-10-18 | 1.65 | 21.74 B$    |
| 2025-10-24 | 1.65 | 21.74 B$    |

**Analysis:**

*Note: There appears to be a duplicate entry for 2025-10-24. Assuming the earlier entry is 2024-10-18 instead.*

*   **Trend:**  Revenue and EPS have fluctuated. Revenue appears to be trending upwards.
*   **Consistency:** EPS has been inconsistent.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $22.39B   | 51.37%        |
| 2025-06-30   | $20.89B   | 49.11%        |
| 2025-03-31   | $19.78B   | 50.98%        |
| 2024-12-31   | $21.88B   | 52.39%        |
| 2024-09-30   | $21.74B   | 52.06%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-09-30   | $53.27B   | 8.92% |
| 2025-06-30   | $52.01B   | 6.95% |
| 2025-03-31   | $52.27B   | 7.21% |
| 2024-12-31   | $51.17B   | 9.05% |
| 2024-09-30   | $51.84B   | 7.64% |

**Analysis:**

*   **Revenue:** Revenue shows a slight upward trend over the past five quarters.
*   **Profit Margin:** Profit margins have been relatively stable, hovering around 50-52%.
*   **Equity:** Equity has been increasing over the period.
*   **ROE:** Return on Equity (ROE) has fluctuated, and is currently at 8.92%. This is a moderate ROE, indicating decent profitability but not exceptional.

**7) Comprehensive Analysis (Summary)**

**Overall Assessment:**

The data paints a mixed picture for Procter & Gamble (PG).

*   **Underperformance:** PG has significantly underperformed the S&P 500 recently. However, recent relative divergence suggests some improvement.
*   **Recent Price Action:** Recent price action suggests a short-term downtrend, with the current price below key moving averages.
*   **Analyst Sentiment:** While the overall analyst consensus is "Buy", the recent trends need to be looked at.

**Key Considerations:**

*   **Efficiency & Valuation:** The recent news of Jefferies upgrading PG after Reassessing Valuation and AI-Driven Efficiency is positive, suggesting that improvements in efficiency and valuation could lead to future gains.

**Recommendation:**

Based on the information, a cautious approach is warranted. While analyst ratings and news point toward some positive catalysts, the underperformance and recent price action cannot be ignored. Investors should conduct thorough research, consider their own risk tolerance, and closely monitor PG's performance in the coming quarters before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.